StonvexLoading…
StonvexStonvexStonvexCore line items from ABBV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $61.16B | $56.33B | $54.32B | $58.05B |
Operating Income | $15.07B | $9.14B | $12.76B | $18.12B |
Net Income | $4.23B | $4.28B | $4.86B | $11.84B |
EPS (Diluted) | $2.36 | $2.39 | $2.72 | $6.63 |
Total Assets | $133.96B | $135.16B | $134.71B | $138.81B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.23B | $5.52B | $12.81B | $9.20B |
Free Cash Flow OCF − CapEx | $17.82B | $17.83B | $22.06B | $24.25B |
Shares Outstanding | 1.77B | 1.77B | 1.77B | 1.78B |